Maria Pinzon-Ortiz

Chronic Treatment with the γ-Secretase Inhibitor LY-411,575 Inhibits β-Amyloid Peptide Production and Alters Lymphopoiesis and Intestinal Cell Differentiation

Gwendolyn T. Wong, Denise Manfra, Frederique M. Poulet et al. · Journal of Biological Chemistry · 2004 · 715 citations · Full text

CDK 4/6 Inhibitors Sensitize PIK3CA Mutant Breast Cancer to PI3K Inhibitors

Sadhna Vora, Dejan Juric, Nayoon Kim et al. · Cancer Cell · 2014 · 428 citations · Full text

Pi3k Inhibitors, Breast Oncology, Medicine +10

A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models

Jeffrey L. Brown, Zhe Cao, Maria Pinzon-Ortiz et al. · Molecular Cancer Therapeutics · 2010 · 150 citations · Full text

Immunology, Vegf Inhibitors, Tumor Biology +16

The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer models

Sunkyu Kim, Ralph Tiedt, Alice Loo et al. · Oncotarget · 2018 · 88 citations · Full text

Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade

Kartik Sehgal, Andrew Portell, Elena V. Ivanova et al. · Journal of Clinical Investigation · 2020 · 67 citations · Full text

Cell Therapy, Pd-1 Blockade, Immunology +24